Sentinel lymph node biopsy: not yet standard of care for melanoma
- PMID: 15258079
- PMCID: PMC478238
- DOI: 10.1136/bmj.329.7458.170
Sentinel lymph node biopsy: not yet standard of care for melanoma
Comment in
-
Completion lymphadenectomy may not increase in-transit disease in malignant melanoma.BMJ. 2004 Nov 27;329(7477):1288-9. doi: 10.1136/bmj.329.7477.1288-c. BMJ. 2004. PMID: 15564269 Free PMC article. No abstract available.
Comment on
-
Sentinel lymph node biopsy.BMJ. 2004 Jun 5;328(7452):1330-1. doi: 10.1136/bmj.328.7452.1330. BMJ. 2004. PMID: 15178590 Free PMC article. No abstract available.
References
-
- Roberts DL, Anstey AV, Barlow RJ, Cox NH, Newton Bishop J, Corrie PG, et al. UK guidelines for the management of cutaneous melanoma. Br J Dermatol 2002;146: 7-17. - PubMed
-
- Wheatley K, Ives N, Hancock B, Gore M, Eggermont A, Suciu S. Does adjuvant interferon-alpha for high risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trails. Cancer Treat Rev 2003;29: 241-52. - PubMed
-
- Thomas JM, Clark MA. Does completion lymphadenectomy in sentinel node positive patients increase the risk of local and in-transit recurrence in melanoma? Eur J Surg Oncol 2004. (in press). doi 10.1016/j.ejso.2004.04.004. - PubMed
-
- Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230: 453-63. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical